Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Lymphoma, Non-Hodgkin

Known as: Lymphoma, Non Hodgkin's, Diffuse Small Cleaved Cell Lymphoma, Lymphoma, Small Cleaved Cell, Diffuse 
Any of a large group of cancers of lymphocytes (white blood cells). NHLs can occur at any age and are often marked by lymph nodes that are larger… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Glyphosate is the most widely used broad-spectrum systemic herbicide in the world. Recent evaluations of the carcinogenic… Expand
  • table 1
  • table 6
  • table 8
  • table 9
  • figure 2
Is this relevant?
Review
2019
Review
2019
PURPOSE Nivolumab, an anti-programmed death-1 monoclonal antibody, has demonstrated frequent and durable responses in relapsed… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2019
Review
2019
BACKGROUND Sintilimab (Innovent Biologics, Suzhou, China), a highly selective, fully humanised, monoclonal antibody, blocks the… Expand
Is this relevant?
Review
2018
Review
2018
Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of a fatal malignancy known as adult T-cell leukemia (ATL… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Review
2018
Review
2018
A major obstacle for chimeric antigen receptor (CAR) T cell therapy in solid tumors is the lack of truly tumor-specific target… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
Review
2018
Review
2018
  • W. Alexander
  • P & T : a peer-reviewed journal for formulary…
  • 2018
  • Corpus ID: 3622141
We review key sessions on Hodgkin's lymphoma, diffuse large B-cell lymphoma, thromboembolism, hemophilia, sickle cell disease… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin's lymphoma, is clinically heterogeneous: 40% of… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
BACKGROUND High-dose chemotherapy followed by autologous bone marrow transplantation is a therapeutic option for patients with… Expand
Is this relevant?
Highly Cited
1993
Highly Cited
1993
BACKGROUND Although many patients with intermediate-grade or high-grade (aggressive) non-Hodgkin's lymphoma are cured by… Expand
Is this relevant?
Highly Cited
1993
Highly Cited
1993
BACKGROUND CHOP is a first-generation, combination-chemotherapy regimen consisting of cyclophosphamide, doxorubicin, vincristine… Expand
Is this relevant?